In addition, somatic genetic analysis of a subset of HER2 positive breast cancers in this study were also conducted by the French Institut National of Cancer (INCa) in the framework of the International Cancer Genomic Consortium.9–11. The gene discussed is ERBB2; the disease is breast carcinoma.